Skip to content
MMJ Gazette
  Sunday 1 June 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
May 29, 2025Ohio Ups Recreational Cannabis Purchase Quantities as Lawmaker Changes Loom May 23, 2025Texas House Passes Near-Total Ban on Hemp-Derived THC, Threatening $5.5 Billion Industry May 15, 2025California Governor Won’t Stop July Increase in Marijuana Excise Tax May 10, 2025Trulieve Workers Make Labor History with Arizona’s First Marijuana Cultivation Union Contract in 25 Years May 10, 2025Canopy Growth Faces Class-Action Lawsuit After Poor Earnings Report April 20, 2025Arizona Cannabis Sales Decline for Second Consecutive Year April 18, 2025Congressional Bills Aim to Provide Federal Marijuana Tax Relief and Limited Descheduling April 9, 2025Pennsylvania’s Plan for State-Run Marijuana Shops Hits a Federal Wall April 9, 2025Minnesota Judge Clears Path for Legal Weed Sales as Rulebook Gets Final Approval April 8, 2025Colorado Greenlights Doctor Prescriptions of Psilocybin Once FDA Gives the Nod, Virginia Says Not Yet
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Drugs  Court Documents Suggest DEA Rigged Marijuana Rescheduling Process
DrugsMarijuanaNews

Court Documents Suggest DEA Rigged Marijuana Rescheduling Process

Lars BeckersLars Beckers—March 10, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Newly surfaced court documents have reignited suspicions that the U.S. Drug Enforcement Administration (DEA) intentionally stacked the deck against marijuana rescheduling. A lawsuit filed by a group of pro-cannabis doctors claims the agency handpicked participants to tilt the outcome in its favor—excluding key voices that supported the change.

The lawsuit, filed by Doctors for Drug Policy Reform (DDPR) in the U.S. Court of Appeals for the D.C. Circuit, points to internal DEA records showing a questionable selection process. Of 163 applicants, only 25 were chosen under undisclosed criteria, while officials from cannabis-friendly states like New York and Colorado were outright rejected. Even more concerning, the documents suggest the DEA actively assisted nearly a dozen opponents of marijuana rescheduling.

With the cannabis industry watching closely, these revelations fuel skepticism over whether the rescheduling process is truly impartial—or if it’s just another bureaucratic blockade to maintain the status quo.

Evidence of Bias Sparks Legal Battle

DDPR’s lawsuit, originally filed in November, seeks transparency. The group wants the DEA to either redo the witness selection process or, at the very least, explain how it made its choices.

For Dr. Bryon Adinoff, an addiction psychiatrist and president of DDPR, the court documents confirm long-standing fears. “It confirms what we thought,” he told MJBizDaily, pointing to the DEA’s selective approval of testimonies.

• The agency allowed testimony from just 25 individuals out of 163 who applied.
• Rejections included officials from pro-cannabis states like New York and Colorado.
• The DEA allegedly assisted nearly a dozen opponents of rescheduling.

If the DEA’s process was indeed rigged, Adinoff argues that stopping or restarting it would be better than allowing a biased decision to stand. “We’re better off arguing the case where we are now than going forward and having it not work in our favor,” he said.

Why Rescheduling Matters for the Cannabis Industry

The push to move marijuana from Schedule 1 to Schedule 3 under federal law is more than just symbolic. The $32 billion U.S. cannabis industry stands to gain major financial benefits, particularly when it comes to taxes.

Under current law, cannabis businesses are barred from deducting standard expenses due to IRS tax code 280E, which applies to Schedule 1 and Schedule 2 substances. Rescheduling would lift that restriction, allowing businesses to operate under fairer tax rules.

It could also open the door for broader cannabis reform at the federal level. Some believe that a DEA endorsement of rescheduling could pressure Congress to take further action on stalled marijuana policy changes.

Ongoing Appeal Seeks to Remove DEA from the Process

The DEA has long been accused of obstructing cannabis policy reform. The latest legal battle isn’t just about this specific rescheduling attempt—it’s about whether the DEA should have the final say at all.

A separate appeal argues that the DEA should be removed as the primary decision-maker on marijuana scheduling, given its history of resistance. That case remains unresolved, but it signals growing frustration with how the agency handles cannabis-related decisions.

For now, the DEA maintains that it followed legal protocol. But with more documents coming to light, the pressure is mounting for the agency to defend its process—or risk losing credibility altogether.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Pre-Rolls Poised to Overtake Flower as Top Cannabis Product in Canada
High Tide Expands in Ontario with Two New Canna Cabana Stores
Related posts
  • Related posts
  • More from author
Marijuana

Ohio Ups Recreational Cannabis Purchase Quantities as Lawmaker Changes Loom

May 29, 20250
Cannabis

Texas House Passes Near-Total Ban on Hemp-Derived THC, Threatening $5.5 Billion Industry

May 23, 20250
News

California Governor Won’t Stop July Increase in Marijuana Excise Tax

May 15, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Ohio Ups Recreational Cannabis Purchase Quantities as Lawmaker Changes Loom
  • Texas House Passes Near-Total Ban on Hemp-Derived THC, Threatening $5.5 Billion Industry
  • California Governor Won’t Stop July Increase in Marijuana Excise Tax
  • Trulieve Workers Make Labor History with Arizona’s First Marijuana Cultivation Union Contract in 25 Years
  • Canopy Growth Faces Class-Action Lawsuit After Poor Earnings Report
  • Arizona Cannabis Sales Decline for Second Consecutive Year
  • Congressional Bills Aim to Provide Federal Marijuana Tax Relief and Limited Descheduling
  • Pennsylvania’s Plan for State-Run Marijuana Shops Hits a Federal Wall
  • Minnesota Judge Clears Path for Legal Weed Sales as Rulebook Gets Final Approval
  • Colorado Greenlights Doctor Prescriptions of Psilocybin Once FDA Gives the Nod, Virginia Says Not Yet
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors